(Q40141213)

17 September 2017

title

BCL2L2 is a probable target for novel 14q11.2 amplification detected in a non-small cell lung cancer cell line (English)

1 reference

17 September 2017

1 reference

3

Hitoshi Tsuda

1 reference

17 September 2017

Tsutomu Kawasaki

1

1 reference

17 September 2017

Sana Yokoi

2

1 reference

17 September 2017

Hiroyuki Izumi

4

1 reference

17 September 2017

Ken-Ichi Kozaki

5

1 reference

17 September 2017

Shinsuke Aida

6

1 reference

17 September 2017

Yuichi Ozeki

7

1 reference

17 September 2017

Yasuyuki Yoshizawa

8

1 reference

17 September 2017

Issei Imoto

9

1 reference

17 September 2017

Johji Inazawa

10

1 reference

17 September 2017

publication date

24 April 2007

1 reference

17 September 2017

1 reference

17 September 2017

volume

98

1 reference

17 September 2017

issue

7

1 reference

17 September 2017

page(s)

1070-1077

1 reference

Epidermal growth factor receptor mutations, small-molecule kinase inhibitors, and non-small-cell lung cancer: current knowledge and future directions

17 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00491.X

Assembly of microarrays for genome-wide measurement of DNA copy number

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00491.X

Genomic microarrays in human genetic disease and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00491.X

Comparative genomic hybridization (CGH)-arrays pave the way for identification of novel cancer-related genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00491.X

Oncogene amplification in solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00491.X

A novel target gene, SKP2, within the 5p13 amplicon that is frequently detected in small cell lung cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00491.X

Screening of DNA copy-number aberrations in gastric cancer cell lines by array-based comparative genomic hybridization

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00491.X

Involvement of cyclin D3 in liver metastasis of colorectal cancer, revealed by genome-wide copy-number analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00491.X

Frequent silencing of DBC1 is by genetic or epigenetic mechanisms in non-small cell lung cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00491.X

Frequent silencing of the candidate tumor suppressor PCDH20 by epigenetic mechanism in non-small-cell lung cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00491.X

Bcl-w(edding) with mitochondria

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00491.X

Tissue expression and subcellular localization of the pro-survival molecule Bcl-w

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00491.X

Bcl-w expression in colorectal adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00491.X

Met/HGF receptor modulates bcl-w expression and inhibits apoptosis in human colorectal cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00491.X

Bax and other pro-apoptotic Bcl-2 family "killer-proteins" and their victim the mitochondrion

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00491.X

Apoptosis regulator bcl-w is essential for spermatogenesis but appears otherwise redundant

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00491.X

Cancer. Addiction to oncogenes--the Achilles heal of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00491.X

Mechanisms of disease: Oncogene addiction--a rationale for molecular targeting in cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00491.X

Oncogene addiction: role of signal attenuation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00491.X

N-(4-hydroxyphenyl)retinamide-induced apoptosis triggered by reactive oxygen species is mediated by activation of MAPKs in head and neck squamous carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00491.X

Bcl-w promotes gastric cancer cell invasion by inducing matrix metalloproteinase-2 expression via phosphoinositide 3-kinase, Akt, and Sp1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00491.X

Lineage dependency and lineage-survival oncogenes in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00491.X

Identification and validation of oncogenes in liver cancer using an integrative oncogenomic approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00491.X

Multiple interacting oncogenes on the 8p11-p12 amplicon in human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00491.X

10.1111/J.1349-7006.2007.00491.X

21 January 2018

Identifiers

DOI

1 reference

17 September 2017

1 reference